InterCure Stock

InterCure P/B

P/B (Price-to-Book Ratio) of InterCure (INCR.TA) as of Aug 5, 2026.

P/B

0.00

Last updated:

P/B (Price-to-Book Ratio) of InterCure is 2026 0.00 . P/B (Price-to-Book Ratio) of InterCure was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) InterCure since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s InterCure with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — InterCure

All Key Metrics — InterCure